Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Conning Inc. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 579 shares of the biopharmaceutical company’s stock after selling 70 shares during […]
Pflug Koory LLC cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,098 shares of the biopharmaceutical company’s stock after selling 15 shares during the […]
Pflug Koory LLC trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.3% during the 2nd quarter, Holdings Channel reports. The fund owned 1,098 shares of the biopharmaceutical company’s stock after selling 15 shares during the period. Pflug Koory LLC’s holdings in Regeneron Pharmaceuticals were worth $789,000 as of its […]
Activest Wealth Management bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 51 shares of the biopharmaceutical company’s stock, valued at approximately $40,000. Other institutional investors and hedge funds have also recently added […]
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twenty-seven brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty have given a buy rating to the […]